Correlation Between Inhibrx and Rallybio Corp
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Rallybio Corp, you can compare the effects of market volatilities on Inhibrx and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Rallybio Corp.
Diversification Opportunities for Inhibrx and Rallybio Corp
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibrx and Rallybio is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Inhibrx i.e., Inhibrx and Rallybio Corp go up and down completely randomly.
Pair Corralation between Inhibrx and Rallybio Corp
Given the investment horizon of 90 days Inhibrx is expected to generate 0.74 times more return on investment than Rallybio Corp. However, Inhibrx is 1.36 times less risky than Rallybio Corp. It trades about -0.02 of its potential returns per unit of risk. Rallybio Corp is currently generating about -0.11 per unit of risk. If you would invest 1,514 in Inhibrx on December 30, 2024 and sell it today you would lose (102.00) from holding Inhibrx or give up 6.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Rallybio Corp
Performance |
Timeline |
Inhibrx |
Rallybio Corp |
Inhibrx and Rallybio Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Rallybio Corp
The main advantage of trading using opposite Inhibrx and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Rallybio Corp vs. Century Therapeutics | Rallybio Corp vs. Edgewise Therapeutics | Rallybio Corp vs. C4 Therapeutics | Rallybio Corp vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |